Search results for "Alcohol"

showing 10 items of 1798 documents

Synthesis and Oxidant Properties of Phase 1 Benzepine N-Oxides of Common Antipsychotic Drugs

2013

There is increasing evidence that cell constituents are oxidized by widely used antipsychotic drugs but until now the underlying chemistry has remained unclear. It is well known that such drugs readily undergo N-oxidation as a first key metabolic step. To gain insight into the problem, the tertiary phase 1 N-oxides of clozapine, olanzapine, quetiapine, and zotepine were synthesized, together with the N,S-dioxides of quetiapine and zotepine. These N-oxides were then subjected to well-established chemical transformations to test their oxidant properties in group VIII transition-metal­-catalyzed reactions. In the osmium tetroxide catalyzed dihydroxylation of styrene or cinnamyl alcohol and in …

OlanzapineCinnamyl alcoholChemistryOrganic ChemistryRedoxCatalysischemistry.chemical_compoundTetrapropylammonium perruthenateZotepineDihydroxylationmedicineOrganic chemistryQuetiapineClozapinemedicine.drugSynthesis
researchProduct

The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature ove…

2014

In addition to tobacco and alcohol consumption, the two main risk factors for oral squamous cell carcinoma (OSCC), recent studies have revealed infections with human papilloma virus (HPV) as an additional risk factor for OSCC development. In the field of head and neck malignancies, the prevalence of HPV infections in oropharyngeal cancer (OC) ranges in different studies up to 84%. While HPV infection is discussed as an independent risk factor in this region, its distinguished role in carcinogenesis of tumours localized to the oral cavity remains still uncertain. In this study, we analysed the HPV status in 88 consecutive patients with OSCCs localized anterior of the palatoglossal arch who w…

OncologyAdultMalemedicine.medical_specialtyPathologyAlcohol DrinkingCarcinogenesisCellAlphapapillomavirusmedicine.disease_causePalatine tonsilYoung AdultSex FactorsInternal medicineGermanyPrevalenceMedicineHumansRisk factorAgedNeoplasm StagingRetrospective StudiesHuman papilloma virusAged 80 and overHuman papillomavirus 16Human papillomavirus 18business.industryPapillomavirus InfectionsSmokingHPV infectionAge Factorsvirus diseasesCancerMiddle Agedmedicine.diseasestomatognathic diseasesOropharyngeal Neoplasmsmedicine.anatomical_structureOtorhinolaryngologyOral and maxillofacial surgeryCarcinoma Squamous CellSurgeryFemaleMouth NeoplasmsOral SurgerybusinessCarcinogenesisJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
researchProduct

Hepatocellular carcinoma: comparison of two different periods at the same center.

2010

Aims: To analyze the main etiological factors and some clinical characteristics of patients with HCC at diagnosis and to compare them with those we described ten years ago. Methods: 179 patients were included in Group 1, while 132 patients were included in Group 2. For all patients age, sex, serum markers of hepatitis B and C viruses, alcohol consumption, serum alpha feto-protein (AFP) levels and the main liver function parameters at HCC diagnosis were recorded. Results: Mean age was 66.0 years for Group 1 and 69.0 for Group 2 (P=0.005). HCV was responsible for 80.3% of HCC cases in Group 2 versus 72% in Group 1 (P=0.005). HBV alone and co-infection of HCV+HBV decreased, but not significant…

OncologyAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaCarcinoma HepatocellularTime FactorsAlcohol DrinkingAlpha (ethology)Gastroenterologyhepatocellular carcinoma Etiology Staging DiagnosisLiver diseaseLiver Function TestsInternal medicineInternal MedicinemedicineHumansAgedNeoplasm StagingAged 80 and overmedicine.diagnostic_testbusiness.industryLiver NeoplasmsHepatitis CHepatitis BMiddle Agedmedicine.diseaseHepatitis BHepatitis Cdigestive system diseasesItalyHepatocellular carcinomaEtiologyFemaleLiver functionalpha-FetoproteinsLiver function testsbusinessEuropean journal of internal medicine
researchProduct

Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol depe…

2012

Background Several lines of evidence from previous research indicate that opioid receptors play an important role in ethanol reinforcement and alcohol dependence (AD) risk. Conflicting results were reported on the role of the mu-opioid receptor (OPRM1) polymorphism A118G (Asn40Asp, rs1799971) in the development of alcoholism. Methods We investigated a total number of 1,845 alcohol-dependent subjects recruited from inpatient facilities in Germany and 1,863 controls for the mu-opioid receptor (OPRM1) polymorphism using chi-square statistics. Results An association between the OPRM variant and AD was detected (p = 0.022), in recessive (AA vs. GA/GG) and co-dominant (AA vs. GA) models of inheri…

OncologyAdultMalemedicine.medical_specialtymedicine.drug_classReceptors Opioid muMedicine (miscellaneous)Locus (genetics)AlcoholToxicologychemistry.chemical_compoundOpioid receptorInternal medicineGenetic variationmedicineHumansReceptorGenetic Association StudiesGeneticsAlcohol dependenceGenetic VariationMiddle AgedPsychiatry and Mental healthAlcoholismTreatment OutcomechemistryOpioidGenetic LociPopulation SurveillanceMultiple comparisons problemFemalePsychologymedicine.drugAlcoholism, clinical and experimental research
researchProduct

The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives

2019

In recent decades, non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in the Western world, and the occurrence of its complications, such as hepatocellular carcinoma (HCC), has rapidly increased. Obesity and diabetes are considered not only the main triggers for the development of the disease, but also two independent risk factors for HCC. Single nucleotide polymorphisms (such as PNPLA3, TM6SF2 and MBOAT7) are related to the susceptibility to the development of HCC and its progression. Therefore, an appropriate follow-up of these patients is needed for the early diagnosis and treatment of HCC. To date, international guidelines recommend the use of ultrasonogr…

OncologyHepatocellular carcinomaDiseaseReviewlcsh:ChemistryLiver disease0302 clinical medicineDisease ScreeningRisk FactorsMass ScreeningHCClcsh:QH301-705.5SpectroscopyFatty liverLiver NeoplasmsGeneral MedicineComputer Science Applications030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyMiRNAmedicine.medical_specialtyMicro RNACarcinoma HepatocellularSingle-nucleotide polymorphismCatalysisTM6SF2Inorganic ChemistryDiabetes Complications03 medical and health sciencesDiabetes mellitusInternal medicineNAFLDmedicineAnimalsHumansObesityPhysical and Theoretical ChemistryMolecular BiologyPNPLA3Long non-conding RNAbusiness.industryOrganic Chemistrymedicine.diseasedigestive system diseasesLncRNAlcsh:Biology (General)lcsh:QD1-999businessTM6SF2Non-alcoholic fatty liver disease
researchProduct

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

2012

BACKGROUND & AIMS: The Sorafenib Hepatocellular Carcinoma (HCC) Assessment Randomized Protocol (SHARP) trial demonstrated that sorafenib improves overall survival and is safe for patients with advanced HCC. In this trial, 602 patients with well-preserved liver function (>95% Child-Pugh A) were randomized to receive either sorafenib 400mg or matching placebo orally b.i.d. on a continuous basis. Because HCC is a heterogeneous disease, baseline patient characteristics may affect individual responses to treatment. In a comprehensive series of exploratory subgroup analyses, data from the SHARP trial were analyzed to discern if baseline patient characteristics influenced the efficacy and safety o…

OncologyMaleTime FactorsMedizinKaplan-Meier EstimateSeverity of Illness Indexlaw.inventionAntineoplastic Agent0302 clinical medicineRandomized controlled triallawMedicineOverall survivalDisease control rateFatigueTime to progressionHazard ratioLiver Neoplasmshepatocellular carcinomaMiddle AgedSorafenib3. Good healthTumor BurdenAlcoholismSubset analysesLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaDisease Progression030211 gastroenterology & hepatologyFemaleHand-Foot SyndromeHumanmedicine.drugPhenylurea CompoundSorafenibDiarrheaNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularTime FactorAntineoplastic AgentsPlacebo03 medical and health sciencesHepatitis B ChronicInternal medicineHumansneoplasmsAgedNeoplasm StagingProportional Hazards ModelsPerformance statusHepatologybusiness.industryPhenylurea CompoundsHepatitis C Chronicmedicine.diseasedigestive system diseasesSurgeryClinical trialProportional Hazards ModelLiver functionbusinessJournal of hepatology
researchProduct

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib

2021

Background Hepatocellular carcinoma (HCC) treatment remains a big challenge in the field of oncology. The liver disease (viral or not viral) underlying HCC turned out to be crucial in determining the biologic behavior of the tumor, including its response to treatment. The aim of this analysis was to investigate the role of the etiology of the underlying liver disease in survival outcomes. Patients and methods We conducted a multicenter retrospective study on a large cohort of patients treated with lenvatinib as first-line therapy for advanced HCC from both Eastern and Western institutions. Univariate and multivariate analyses were performed. Results Among the 1232 lenvatinib-treated HCC pat…

OncologyPhenylurea CompoundatezolizumabCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularQuinolinelenvatinibbevacizumabchemistry.chemical_compoundLiver diseaseRetrospective StudieNon-alcoholic Fatty Liver DiseaseInternal medicineMedicineHumansnonalcoholic steatohepatitisOriginal ResearchRetrospective StudiesUnivariate analysisSettore MED/12 - GastroenterologiaPerformance statusbusiness.industryPhenylurea CompoundsHazard ratioLiver NeoplasmsRetrospective cohort studyHepatitis Chepatocellular carcinomamedicine.diseasePrognosisdigestive system diseasesadvanced hepatocarcinoma; atezolizumab; bevacizumab; hepatitis C; hepatocellular carcinoma; immunotherapy; lenvatinib; nonalcoholic steatohepatitis; sorafenibadvanced hepatocarcinomaOncologychemistryLiver NeoplasmHepatocellular carcinomanonalcoholic steatohepatitiQuinolinessorafenibimmunotherapyhepatitis CbusinessLenvatinibHuman
researchProduct

Surgical therapy of liver cancer: resection and transplantation

2008

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is estimated to cause approximately half a million deaths per year. Most tumours (80%) develop in cirrhotic livers caused by viral hepatitis C or B and alcoholic liver disease. In the natural course survival depends on the stage of the disease. At an early stage 3-year survival is 65% without treatment, in the intermediate stage between 10% and 50% of patients are reported to be alive after 2 years, and in the final stage median survival only rarely exceeds 6 months. Surgical treatment is capable of doubling survival. The results of local ablative treatment in early carcinoma are very similar to surgical treatment1…

Oncologymedicine.medical_specialtyAlcoholic liver diseasebusiness.industryCancermedicine.diseaseSurgeryTransplantationLiver diseaseHepatocellular carcinomaInternal medicinemedicineStage (cooking)businessLiver cancerViral hepatitis
researchProduct

NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options

2022

In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important underlying aetiology of hepatocellular carcinoma (HCC). HCCs arising from lipotoxicity-mediated chronic inflammation are characterised by several unique features: in contrast to virally driven HCC, up to 50% of NAFLD-HCC occurs in patients without cirrhosis and annual HCC incidence is comparatively low, complicating current surveillance strategies. On average, patients are older and are more frequently diagnosed at an advanced stage. While locoregional treatments are probably equally effective regardless of HCC aetio…

Oncologymedicine.medical_specialtyCarcinoma HepatocellularCirrhosisDiseaseType 2 diabetesNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicinemedicineHumansneoplasmsHepatologybusiness.industryLiver NeoplasmsFatty livermedicine.diseasedigestive system diseasesLiver TransplantationClinical trialTreatment OutcomeLiverHepatocellular carcinomaDisease ProgressionMetabolic syndromeSteatohepatitisbusinessJournal of Hepatology
researchProduct

Functional Connectivity of Nucleus Accumbens and Medial Prefrontal Cortex With Other Brain Regions During Early-Abstinence Is Associated With Alcohol…

2021

Background: Alcohol dependence (AD) is a chronic recurrent brain disease that causes a heavy disease burden worldwide, partly due to high relapse rates after detoxification. Verified biomarkers are not available for AD and its relapse, although the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC) may play important roles in the mechanism of addiction. This study investigated AD- and relapse-associated functional connectivity (FC) of the NAc and mPFC with other brain regions during early abstinence.Methods: Sixty-eight hospitalized early-abstinence AD male patients and 68 age- and education-matched healthy controls (HCs) underwent resting-functional magnetic resonance imaging (r-f…

Oncologymedicine.medical_specialtyrest-functional magnetic resonance imaginglcsh:RC435-571media_common.quotation_subjectalcohol dependencepredictorNucleus accumbensbehavioral disciplines and activitiesGyrusInternal medicinelcsh:PsychiatrymedicinePrefrontal cortexmedia_commonOriginal ResearchPsychiatryrelapsemedicine.diagnostic_testbusiness.industryAddictionAlcohol dependencefunctional connectivityrelapse severityMagnetic resonance imagingAbstinencePsychiatry and Mental healthmedicine.anatomical_structurenervous systemFunctional magnetic resonance imagingbusinesspsychological phenomena and processesFrontiers in Psychiatry
researchProduct